EUVIMEDEUVIMED entdecken
Open Access

An Empirical Quantitative Structure-Activity Relationship Equation Assists the Discovery of High-Affinity Phosphodiesterase 4D Inhibitors as Leads to PET Radioligands

Meijuan Jiang iD, Shuiyu Lu iD, Sanjay Telu iD, Victor W Pike iD

Journal of Medicinal Chemistry · 2023

DOI: 10.1021/acs.jmedchem.2c01745 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Meijuan Jiang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, 10 Center Drive, Bethesda, Maryland 20892-1003, United …. Hauptthemen laut MEDLINE: Phosphodiesterase Inhibitors, Cyclic Nucleotide Phosphodiesterases, Type 4. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, National Institute of Mental Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A positron emission tomography (PET) radioligand for imaging phosphodiesterase 4D (PDE4D) would benefit drug discovery and the investigation of neuropsychiatric disorders. The most promising radioligand to date, namely, [11C]T1650, has shown unstable quantification in humans. Structural elaboration of [11C]T1650 was therefore deemed necessary. High target affinity in the low nM range is usually required for successful PET radioligands. In our PDE4D PET radioligand development, we formulated and optimized an empirical equation (log[IC50 (nM)] = P1 + P2 + P3 + P4) that well described the relationship between binding affinity and empirically derived values (P1-P4) for the individual fragments in four subregions commonly composing each inhibitor (R2 = 0.988, n = 62). This equation was used to predict compounds that would have high inhibitory potency. Fourteen new compounds were obtained with IC50 of 0.3-10 nM. Finally, eight compounds were judged to be worthy of future radiolabeling and evaluation as PDE4D PET radioligands.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phosphodiesterase InhibitorsCyclic Nucleotide Phosphodiesterases, Type 4HumansQuantitative Structure-Activity RelationshipPositron-Emission TomographyBrainStructure-Activity RelationshipLigandsRadiopharmaceuticals

Substanzen

Phosphodiesterase InhibitorsCyclic Nucleotide Phosphodiesterases, Type 4LigandsRadiopharmaceuticals

Autor:innen und Institutionen

  • Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, 10 Center Drive, Bethesda, Maryland 20892-1003, United States.

ORCID-Profile: Meijuan Jiang, Shuiyu Lu, Sanjay Telu, Victor W Pike

Förderung

  • Intramural NIH HHS
  • National Institute of Mental Health

Zitieren

APA

Jiang, M., Lu, S., Telu, S., & Pike, V. W. (2023). An Empirical Quantitative Structure-Activity Relationship Equation Assists the Discovery of High-Affinity Phosphodiesterase 4D Inhibitors as Leads to PET Radioligands. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.2c01745

Vancouver

Jiang M, Lu S, Telu S, Pike VW. An Empirical Quantitative Structure-Activity Relationship Equation Assists the Discovery of High-Affinity Phosphodiesterase 4D Inhibitors as Leads to PET Radioligands. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.2c01745

BibTeX
@article{Jiang2023,
  author = {Jiang, Meijuan and Lu, Shuiyu and Telu, Sanjay and Pike, Victor W},
  title = {An Empirical Quantitative Structure-Activity Relationship Equation Assists the Discovery of High-Affinity Phosphodiesterase 4D Inhibitors as Leads to PET Radioligands},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  doi = {10.1021/acs.jmedchem.2c01745}
}
Kostenlos starten →